Role of Oxidative Stress and Antioxidants in Neurodegenerative Diseases

References

• Agarwal, S. and Rao, A.V. (1988 ) “Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study”, Lipids 33, 981–984.
   Web of Science ®Google Scholar
• Agarwal, S. and Rao, A.V. (2000 ) “Carotenoids and chronic Diseases”, Drug Metabolism and Drug Interactions 17, 189–210.
   PubMedGoogle Scholar
• Ahlskog, J.E., Uitti, R.J., Low, P.A., Tyce, G.M., Nickander, K.K., Peterson, R.C. and Kokmen, E. (1995 ) “No evidence for systemic oxidant stress in Parkinson’s or Alzheimer’s disease”, Movement Disorders 10, 566–573.
   PubMed Web of Science ®Google Scholar
• Ahmad, F.F., Cowan, D.L. and Sun, A.Y. (1990 ) “Free radical generation from dopamine through the action of monoamine oxidase (MAO)”, Society of Neuroscience Abstract 350, 9.
   Google Scholar
• Alavi, A., Dann, R., Challuk, J., Alavi, J., Kushner, M. and Reivich, M. (1986 ) “Positron emission tomography imaging of regional cerebral glucose metabolism”, Seminars in Nuclear Medicine 162, 2–34.
   Google Scholar
• Ambani, L.M., Van Woert, M.H. and Murphy, S. (1975 ) “Brain peroxidase and catalase in Parkinson’s disease”, The Archives of Neurology 32, 114–118.
   PubMed Web of Science ®Google Scholar
• Ameer, B., Weintraub, R.A., Jonhson, J.V., Yost, R.V. and Rouseff, R.L. (1996 ) “Flavonone absorption after naringin, hesperidin, and citrus administration”, Clinical Pharmacology and Therapeutics 60, 34–40.
   PubMed Web of Science ®Google Scholar
• Amir, H., Karas, M., Giat, J., Danilenko, M., Levy, R., Yermiahu, T., Levy, J. and Sharoni, Y. (1999 ) “Lycopene and 1,25-dihydroxy- vitamin-D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells”, Nutrition and Cancer 33, 105–112.
   PubMed Web of Science ®Google Scholar
• Andreassen, O.A., Ferrante, R., Klivenyi, P., Klein, A.M., Shinobu, L.A., Epstin, C.J. and Beal, M.F. (2000 ) “Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotophic lateral sclerosis”, Annals of Neurology 47, 447–455.
   PubMed Web of Science ®Google Scholar
• Anneren, G., Gardner, A. and Lundin, T. (1986 ) “Increased glutathione peroxidase activity in erythrocytes in patients with Alzheimer’s disease/senile dementia of Alzheimer’s type”, Acta Neurologica Scandinavica 73, 586–589.
   PubMed Web of Science ®Google Scholar
• Appel, S.H., Smith, R.G., Englehardt, J.I. and Stefani, E. (1993 ) “Evidence for autoimmunity in amyotrophic lateral sclerosis”, Journal Neurological Sciences 118, 169–174.
   PubMed Web of Science ®Google Scholar
• Atwood, C.S., Moir, R.D., Huang, X.D., Scarpa, R.C., Bacarra, N.M.E., Romano, D.M., Hartshorn, M.K., Tanzi, R.E. and Bush, A.I. (1998 ) “Dramatic aggregation of Alzheimer A-beta by Cu (II) is induced by conditions representing physiological acidosis”, Journal of Biological Chemistry 273, 12817–12826.
   PubMed Web of Science ®Google Scholar
• Atwood, C.S., Huang, X., Moir, R.D., Tanzi, R.E. and Bush, A.I. (1999 ) “Role of free radicals and metal ions in the pathogenesis of Alzheimer’s disease”, Metal Ions in Biological System 36, 309–364.
   PubMedGoogle Scholar
• Azzouz, M., Poindron, P., Guettier, S., Leclerc, N., Andres, C., Water, J.M. and Borg, J. (2000 ) “Prevention of mutant SOD1 motorneuron degeneration by copper chelators in vitro”, Journal of Neurobiology 42, 49–55.
   PubMedGoogle Scholar
• Balazs, L. and Leon, M. (1994 ) “Evidence of an oxidative challenge in the Alzheimer’s brain”, Neurochemical Research 19, 1131–1137.
   PubMed Web of Science ®Google Scholar
• Bamford, K.A., Caine, E.D., Kido, D.K., Cox, C. and Shoulson, I. (1995 ) “A prospective evaluation of cognitive decline in early Huntington’s disease: functional and radiographic correlates”, Neurology 45, 1867–1873.
   PubMed Web of Science ®Google Scholar
• Bao, J., Sharp, A.H., Wagster, M.V., Becher, M., Schilling, G., Ross, C. A., Dawson, V.L. and Dawson, T.M. (1996 ) “Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin”, Proceedings of the National Academy of Sciences of the USA 93, 5037–5042.
   PubMed Web of Science ®Google Scholar
• Barbeau, A. (1984 ) “Manganese and extrapyramidal disorders”, Neurotoxicology 5, 3–36.
   Google Scholar
• Bastianetto, S., Ramassamy, C., Dore, S., Christen, Y., Poirier, J. and Quirion, R. (2000 ) “The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by betaamyloid”, European Journal ofNeuroscience 12, 1882–1890.
   PubMed Web of Science ®Google Scholar
• Beal, M.F. (1992 ) “Does impairment of energy metabolism result in excitotoxicity neuronal death in neurodegenerative illness?”, Annals of Neurology 31, 119–130.
   PubMed Web of Science ®Google Scholar
• Beal, M.F. (1996 ) “Mitochondria, free radicals, and neurodegeneration”, Current Opinion in Neurobiology 6, 661–666.
   PubMed Web of Science ®Google Scholar
• Beal, M.F., Henshaw, R., Jenkins, B.G., Rosen, B.R. and Schulz, J.B. (1994 ) “CoenzymeQ10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate”, Annals of Neurology 36, 882–888.
   PubMed Web of Science ®Google Scholar
• Beal, M.F., Ferrante, R.J., Browne, S.E., Matthews, R.T., Kowall, N.W. and Brown, Jr., R.H. (1997 ) “Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis”, Annals of Neurology 42, 644–654.
   PubMed Web of Science ®Google Scholar
• Beckman, J.S., Carson, M., Smith, C.D. and Koppenol, W.H. (1993 ) “ALS, SOD and peroxynitrite”, Nature 364, 584–590.
   PubMed Web of Science ®Google Scholar
• Behl, C., Davis, J., Cole, G.M. and Schubert, D. (1992 ) “Vitamin E protects nerve cells from amyloid beta protein toxicity”, Biochemical and Biophysical Research Communications 186, 944–950.
   PubMed Web of Science ®Google Scholar
• Berger, M.M., Kopp, N., Vital, C., Redl, B., Aymard, M. and Lina, B. (2000 ) “Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS”, Neurology 54, 20–25.
   PubMed Web of Science ®Google Scholar
• Bogdanov, M., Brown, Jr., R.H., Matson, W., Smart, R., Hayden, D., O’Donnell, H., Beal, M.F. and Cudkowicz, M. (2000 ) “Increased oxidative damage to DNA in ALS patients”, Free Radical Biology and Medicine 29, 652–658.
   PubMed Web of Science ®Google Scholar
• Bogdonav, M.B., Ramos, L.E., Xu, Z. and Beal, M.F. (1998 ) “Elevated ‘hydroxyl radical’ generation in vitro in an animal model of amyotrophic lateral sclerosis”, Journal of Neurochemistry 71, 1321–1324.
   PubMed Web of Science ®Google Scholar
• Bonarek, M., Barberger-Gateau, P., Letenneur, L., Deschamps, V., Iron, A., Dubroca, B. and Dartigues, J.F. (2000 ) “Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study”, Neuroepidemiology 19, 141–148.
   PubMed Web of Science ®Google Scholar
• Bowling, A.C., Schulz, J.B., Brown, R.H. and Beal, M.F. (1993 ) “Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis”, Journal of Neurochemistry 61, 2322–2325.
   PubMed Web of Science ®Google Scholar
• Bredt, D.S. and Synder, S.H. (1992 ) “Nitric oxide, a novel neuronal messenger”, Neuron 8, 3–11.
   PubMed Web of Science ®Google Scholar
• Breteler, M.M.B., Amerongen, N.M., Swieten, J.C., Claus, J.J., Grobbee, D.E., Van Gijn, J., Hofman, . and van Harshamp, A. (1994) “Cognitive correlates of ventricular enlargement and cerebral white mater lesions on magnetic resonance. Imaging the Rotterdam Study”, Stroke 25, 1109–1115.
   PubMed Web of Science ®Google Scholar
• Bridi, R., Crossetti, F.P., Steffen, V.M. and Henriques, A.T. (2001 ) “The antioxidant activity of standardized extact of Ginkgo biloba (Egb 761) in rats”, Phytotherapy Research 15, 449–451.
   PubMed Web of Science ®Google Scholar
• Brown, Jr., R.H. (1995 ) “Amyotrophic lateral sclerosis. Insights from genetics and transgenic mice”, Cell 80, 687–692.
   PubMed Web of Science ®Google Scholar
• Bruijn, L.I., Becher, M.W., Lee, M.K., Anderson, K.L., Jenkins, N.A., Copeland, N.G., Sisodia, S.S., Rothstein, J.D., Borchelt, D.R., Price, D.L. and Cleveland, D.W. (1997 ) “ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes and promotes rapidly progressive disease with SOD1-containing inclusions”, Neuron 18, 327–338.
   PubMed Web of Science ®Google Scholar
• Bruijn, L.I., Houseweart, M.K., Kato, S., Anderson, K.L., Anderson, S.D., Ohama, E., Reaume, A.G., Scott, R.W. and Cleveland, D.W. (1998 ) “Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD”, Science 281, 1851–1854.
   PubMed Web of Science ®Google Scholar
• Burke, R.E. (1999) “Parkinson’s disease”, In: Koliatsos, V.E. and Ratan, R.R., eds, Cell Death and Diseases of the Nervous System (Humana Press, Totowa, NJ), pp. 459–475.
   Google Scholar
• Burton, G.W. and Ingold, K.U. (1984 ) “Beta-carotene—an unusual type of lipid antioxidant”, Science 224, 569–573.
   PubMed Web of Science ®Google Scholar
• Bush, A.I. (2000 ) “Metals and neuroscience”, Current Opinion in Chemical Biology 4, 184–191.
   PubMed Web of Science ®Google Scholar
• Butterfield, D.A., Yatin, S.M. and Link, C.D. (1999) “In vitro and in vivo protein oxidation induced by Alzheimer’s disease amyloid ß-peptide (1–42)”, Annals of the New York Academy of Sciences 893, 265–268.
   PubMed Web of Science ®Google Scholar
• Calhoun, M.E., Wiederhold, K.H., Abramowski, D., Phinney, A.L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B. and Jucker, M. (1998 ) “Neuron loss in APP transgenic mice”, Nature 395, 755–756.
   PubMed Web of Science ®Google Scholar
• Campbell, A. (2002 ) “The potential role of aluminium in Alzheimer’s disease”, Nephrology Dialysis Transplantation 17, 17–20.
   PubMed Web of Science ®Google Scholar
• Campbell, W.G., Raskind, M.A., Gordon, T. and Shaw, C.M. (1985 ) “Iron pigment in the brain of a man with tardive dyskinesia”, American Journal of Psychiatry 142, 364–365.
   PubMed Web of Science ®Google Scholar
• Camu, W., Khoris, J., Moulard, B., Salachas, F., Briolotti, V., Rouleau, G.A. and Meninger, V. (1999 ) “Genetics of familial ALS and consequences for diagnosis. French ALS research group”, Journal of the Neurological Sciences 165 (Suppl. 1), S21–S26.
   PubMedGoogle Scholar
• Cao, G. and Prior, R.L. (1998 ) “Comparison of different analytical methods for assessing total antioxidant capacity of tea and common vegetables”, Clinical Chemistry 44, 1309–1315.
   PubMed Web of Science ®Google Scholar
• Chacon, J.N., Chedekel, M.R., Land, E.J. and Truscott, T.G. (1987 ) “Chemically induced Parkinson’s disease: intermediates in the oxidation of 1-methyl-4-phenyl pyridinium ion”, Biochemical and Biophysical Research Communications 144, 957–964.
   PubMed Web of Science ®Google Scholar
• Chen, L., Richardson, J., Caldwell, J. and Ang, L. (1994 ) “Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer’s disease and from nondemented controls”, International Journal of Neuroscience 75, 83–90.
   PubMedGoogle Scholar
• Cleveland, D.W., Bruijn, L.I., Wong, P.C., Marszalek, J.R., Vechio, J.D., Lee, M.K., Xu, X.S., Borchelt, D.R., Sisodia, S.S. and Price, D.L. (1996 ) “Mechanisms of selective motor neuron death in transgenic mouse models of motor neuron disease”, Neurology 47 (Suppl. 2), S54–S62.
   PubMedGoogle Scholar
• Clinton, S.K. (1998 ) “Lycopene: chemistry, biology, and implications for human health and disease”, Nutritional Review 56, 35–51.
   PubMed Web of Science ®Google Scholar
• Cohen, G. (1986 ) “Monoamine oxidase, hydrogen peroxide and Parkinson’s disease”, Advances in Neurology 45, 119–125.
   Google Scholar
• Cohen, G. (1988) “Oxygen radicals and Parkinson’s disease”, In: Halliwell, B., ed, Oxygen Radicals and Tissue Injury (Federation of American Societies for Experimental Biology, Maryland, MD), pp. 130–135.
   Google Scholar
• Cohen, G. and Spina, M.B. (1989 ) “Deprenyl suppresses the oxidant stress associated with increased dopamine turnover”, Annals of Neurology 26, 689–690.
   PubMed Web of Science ®Google Scholar
• Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericakvance, M.A. (1993), Science 261, 921–923.
   PubMed Web of Science ®Google Scholar
• Corson, L.B., Strain, J.J., Culotta, V.C. and Cleveland, D.W. (1998 ) “Chaperone-facilitated sopper binding is a property common to several classes of amyotrophic lateral sclerosis-linked superoxide dismutase mutants”, Proceedings of the National Academy of Sciences of the USA 95, 6361–6366.
   PubMed Web of Science ®Google Scholar
• Coyle, J.T. and Puttfarcken, P. (1993 ) “Oxidative stress, glutamate and neurodegenerative disorders”, Science 262, 689–695.
   PubMed Web of Science ®Google Scholar
• Damier, P., Hirsch, E.C., Zhang, P., Agid, Y. and Javoy-Agid, F. (1993 ) “Glutathione peroxidase, glial cells and Parkinson’s disease”, Neuroscience 52, 1–7.
   PubMed Web of Science ®Google Scholar
• Dawson, V.L., Dawson, T.M., Bartley, D.A., Uhl, G.R. and Snyder, S.H. (1993 ) “Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures”, Journal ofNeurosciences 13, 651–2661.
   Google Scholar
• Dawson, V.L. and Dawson, T.M. (1996 ) “Nitric oxide neurotoxicity”, Journal of Chemical Neuroanatomy 10, 179–190.
   PubMed Web of Science ®Google Scholar
• De Belleroche, J., Orrell, R. and King, A. (1995 ) “Familial amyotrophic lateral sclerosis/motor neuron disease (FALS): a review of current developments”, Journal of Medical Genetics 32, 841–847.
   PubMed Web of Science ®Google Scholar
• Delanty, N. and Dichter, M.A. (2000 ) “Antioxidant therapy in neurologic disease”, The Archives of Neurology 57, 1265–1270.
   PubMed Web of Science ®Google Scholar
• Deng, H.X., Tainer, J.A., Mitsumoto, H., Ohnishi, A., He, X., Hung, W.Y., Zhao, Y., Juneja, T., Hentati, A. and Siddique, T. (1995 ) “Two novel SOD1 mutations in patients with familial amyotrophic lateral sclerosis”, Human Molecular Genetics 4, 1113–1116.
   PubMed Web of Science ®Google Scholar
• De Rijk, M.C., Breteler, M.M., den Breeijen, J.H., Lauren, L.J., Grobbee, D.E., Van der Meche, F.G. and Hoffman, A. (1997 ) “Dietary antioxidants and Parkinson’s disease. The Rotterdam Study”, The Archives of Neurology 54, 1762–1765.
   Google Scholar
• Dexter, D.T., Wells, F.R., Lees, A.J., Agid, F., Agid, Y., Jenner, P. and Marsden, C.D. (1989a ) “Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson’s disease”, Journal of Neurochemistry 52, 1830–1836.
   PubMed Web of Science ®Google Scholar
• Dexter, D.T., Carter, C.J., Wells, F.R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P. and Marsden, C.D. (1989b ) “Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease”, Journal of Neurochemistry 52, 381–389.
   PubMed Web of Science ®Google Scholar
• Dexter, D.T., Holley, A.E., Flitter, W.D., Slater, T.F., Wells, F.R., Daniel, S.E., Lees, A.J., Jenner, P. and Marsden, C.D. (1994 ) “Increased levels of lipid hydroperoxides in the Parkinsonian substantia nigra: an HPLC and ESR study”, Movement and Disorders 9, 92–97.
   PubMed Web of Science ®Google Scholar
• Difiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.P., Carraway, R. and Reeves, S.A. (1995 ) “Huntington is a cytoplasmic protein associated with vesicles in human and rat brain neurons”, Neuron 14, 1075–1081.
   PubMed Web of Science ®Google Scholar
• Dimascio, P., Kaiser, S. and Sies, H. (1989 ) “Lycopene as the most effective biological carotenoid singlet oxygen quencher”, Archives of Biochemistry and Biophysics 274, 32–538.
   Google Scholar
• Elkashef, A.M., Ruskin, P.E., Bacher, N. and Barette, D. (1990 ) “Vitamin E in the treatment of tardive dyskinesia”, American Journal ofPsychiatry 147, 505–506.
   PubMed Web of Science ®Google Scholar
• Elliot, J.L. and Snider, W.D. (1996 ) “Motor neuron growth factors”, Neurology 47 (Suppl. 2), S47–S53.
   PubMedGoogle Scholar
• Fahn, S. (1991 ) “An open trial of high-dosage antioxidants in early Parkinson’s disease”, American Journal of Clinical Nutrition 53, 380–382.
   PubMed Web of Science ®Google Scholar
• Fay, D., Fluet, A., Johnson, C. and Link, C. (1998) “In vivo aggregation of beta-amyloid peptide variants”, Journal of Neurochemistry 71, 1616–1625.
   PubMed Web of Science ®Google Scholar
• Ferrante, R.J., Browne, S.E., Shinobu, L.A., Bowling, A.C., Baik, M.J., MacGarvey, U., Kowall, N.W., Brown, Jr., R.H. and Beal, M.F. (1997a ) “Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis”, Journal of Neurochemistry 69, 2064–2074.
   PubMed Web of Science ®Google Scholar
• Ferrante, R.J., Shinobu, L.A., Schulz, J.B., Matthews, R.T., Thomas, C. E., Kowall, N.W., Gurney, M.E. and Beal, M.F. (1997b ) “Increased3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation”, Annals of Neurology 42, 326–334.
   PubMed Web of Science ®Google Scholar
• Figlenicz, D.A., Garrutao, R.M., Yanagihara, R.Y. and Rouleau, G. (1994 ) “The Cu/Zn superoxide dismutase in ALS and Parkinsonism dementia of Guam”, NeuroReport 5, 557–560.
   PubMed Web of Science ®Google Scholar
• Floyd, R.A. (1999 ) “Antioxidants, oxidative stress, and degenerative neurological disorders”, Proceedings of the Society for Experimental Biology and Medicine 222, 236–245.
   PubMed Web of Science ®Google Scholar
• For the North American EGb Study Group Le Bars, P.L., Katz, M.M., Berman, N., Itil, T.M., Freedman, A.M. and Schatzberg, A.F. (1997) “A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia”, J Am. Med. Assoc. 278, 1327–1332.
   Web of Science ®Google Scholar
• Foy, C.J., Passmore, A.P., Vahidassr, M.D., Young, I.S. and Lawson, J.T. (1999 ) “Plasma chain-breaking antioxidants in Alzheimer’s disease, vascular dementia and Parkinson’s disease”, The Quarterly Journal of Medicine 92, 39–45.
   Google Scholar
• Franceschi, D., Graham, D., Sarasua, M. and Zollinger, Jr., R.M. (1990 ) “Mechanisms of oxygen free radical-induced calcium overload in endothelial cells”, Surgery 108, 292–297.
   PubMed Web of Science ®Google Scholar
• Frankel, E.N., Kanner, J., German, J.B., Parks, E. and Kinsella, J.E. (1993 ) “Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine”, Lancet 341, 454–457.
   PubMed Web of Science ®Google Scholar
• Frautschy, S.A., Hu, W., Kim, P., Miller, S.A., Chu, T., Harris-White, M.E. and Cole, G.M. (2001 ) “Phenolic anti-inflammatory antioxidant reversal of Aß-induced cognitive deficits and neuropathology”, Neurobiology of Aging 22, 993–1005.
   PubMed Web of Science ®Google Scholar
• Frei, B., Forte, T.M., Ames, B.N. and Cross, C.E. (1991 ) “Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid”, Biochemical Journal 277, 133–138.
   PubMed Web of Science ®Google Scholar
• Frolich, L. and Riederer, P. (1995 ) “Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidant treatment”, Drug Research 45, 443–446.
   PubMed Web of Science ®Google Scholar
• Fuhrman, B., Lavy, A. and Aviram, M. (1995 ) “Consumption of red wine with meals reduces the susceptibility of human plasma and low density lipoprotein to lipid peroxidation”, American Journal of Clinical Nutrition 61, 549–554.
   PubMed Web of Science ®Google Scholar
• Furuta, A., Price, D.L., Pardo, C.A., Tronocosao, J.C., Xu, Z.S., Taniguchi, N. and Martin, L.J. (1995 ) “Localization of superoxide dismutases in Alzheimer’s disease and Down’s syndrome neocortex and hippocampus”, American Journal ofPathology 146, 357–367.
   PubMed Web of Science ®Google Scholar
• Ganzini, L., Heintz, R.T., Hoffman, W.F. and Casey, D.E. (1991 ) “The prevalence of tardive dyskinesia in neuroleptic treated diabetics”, Archives of General Psychiatry 48, 259–263.
   PubMed Web of Science ®Google Scholar
• Gattaz, W.F., Emrich, A. and Behrens, S. (1993 ) “Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia”, Journal of Neural Transmission 92, 197–201.
   PubMed Web of Science ®Google Scholar
• Gearing, M., Mori, H. and Mirra, S.S. (1996 ) “Abeta-peptide length and apolipoprotein E genotype in Alzheimer’s disease”, Annals of Neurology 39, 395–399.
   PubMed Web of Science ®Google Scholar
• Geldmacher, D.S. and Whitehouse, P.J. (1996 ) “Evaluation of dementia”, New England Journal of Medicine 335, 330–336.
   PubMed Web of Science ®Google Scholar
• Gilgun-Sherki, Y., Melamed, E. and Often, D. (2001 ) “Oxidative stress-induced neurodegenerative diseases: the need for antioxidants that penetrate the blood-brain barrier”, Neuropharmacology 40, 959–975.
   PubMed Web of Science ®Google Scholar
• Gilliam, T.C., Bucan, M., Macdonald, M.E., Zimmer, M., Haines, J.L., Cheng, S.V., Pohl, T.M., Meyers, R.H., Whaley, W.L. and Allitto, B.A. (1987 ) “A DNA segment encoding two genes very tightly linked to Huntington’s disease”, Science 238, 950–952.
   PubMed Web of Science ®Google Scholar
• Goodwin, J.S., Goodwin, J.M. and Garry, P.J. (1983 ) “Association between nutritional status and cognitive functioning in a healthy elderly population”, Journal of American Medical Association 249, 2917–2921.
   PubMed Web of Science ®Google Scholar
• Greenamyre, J.T. (1986 ) “The role of glutamate in neurotransmission and in neurologic disease”, The Archives ofNeurology 43, 1058–1063.
   PubMedGoogle Scholar
• Grundman, M. (2000 ) “Vitamin E and Alzheimer’s disease: the basis for additional clinical trials”, American Journal of Clinical Nutrition 71 (Suppl.), 630S-636S.
   PubMedGoogle Scholar
• Grünewald, T. and Beal, M.F. (1999 ) “Bioenergetics in Huntington’s disease”, Annals of the New York Academy of Sciences 893, 203–213.
   PubMed Web of Science ®Google Scholar
• Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H.X., Chen, W., Zhai, P., Sufit, R.L. and Siddique, T. (1994 ) “Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation”, Science 264, 1772–1775.
   PubMed Web of Science ®Google Scholar
• Halliwell, B. (1989 ) “Oxidants and the central nervous system: some fundemental questions”, Acta Neurologica Scandinavica 126, 23–33.
   Google Scholar
• Halliwell, B. and Gutteridge, J. (1985 ) “Oxygen radicals and the nervous system”, Trends in Neurosciences 8, 22–26.
   Web of Science ®Google Scholar
• Halliwell, B., Cross, C.E. and Gutteridge, J.M.C. (1992 ) “Free radicals, antioxidants and human diseases: where are we now?”, Journal of Laboratory and Clinical Medicine 119, 598–620.
   PubMed Web of Science ®Google Scholar
• Hand, C. and Rouleau, G.A. (2002 ) “Familial amyotrophic lateral sclerosis”, Muscle Nerve 25, 135–259.
   PubMed Web of Science ®Google Scholar
• Haverkamp, L.J., Appel, V. and Apple, S.H. (1995 ) “Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction”, Brain 118, 707–719.
   PubMed Web of Science ®Google Scholar
• Hayden, M.R., Martin, W.R., Stoessl, A.J., Clarke, C., Hollenberg, S., Adam, M.J., Ammann, W., Harrop, R., Rogers, J. and Ruth, T. (1986 ) “Positron emission tomography in the early diagnosis of Huntington’s disease”, Neurology 36, 888–894.
   PubMed Web of Science ®Google Scholar
• Hentati, A., Kwon, Y.W., Deng, H.X., Chen, W., Zhai, P., Sufit, R.L. and Siddique, T. (1994 ) “Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation”, Science 264, 1772–1775.
   PubMed Web of Science ®Google Scholar
• Hesse, L., Beher, D., Masters, C.L. and Multhaup, G. (1994 ) “The bA4 amyloid precursor protein binding to copper”, FEBS Letters 349, 109–116.
   PubMed Web of Science ®Google Scholar
• Hobbs, A.J., Higgs, A. and Moncada, S. (1999 ) “Inhibition of nitric oxide synthase as a potential therapeutic target”, Annual Review of Pharmacology and Toxicology 39, 191–220.
   PubMed Web of Science ®Google Scholar
• Hodis, H.N., Mack, W.J., LaBree, L., Cashin-Hemphill, L., Sevanian, A., Johnson, R. and Azen, S.P. (1995) “Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis”, J. Am. Med. Assoc. 273, 1849–1854.
   PubMedGoogle Scholar
• Hoffman, A., Grobbee, D.E., DeJong, P.T.V.M. and Van den Ouweland, A. (1991) “Determinants of disease and disability in the elderly. The Rotterdam Elderly Study”, European Journal of Epidemiology 7, 403–412.
   PubMed Web of Science ®Google Scholar
• Hofman, A., Ott, A., Breteler, M.M.B., Bots, M.L., Slooter, A.J.C., van Harskamp, F., van Duijn, C.M., van Broeckhoven, C. and Grobbee, D.E. (1997 ) “Atherosclerosis, apolipoprotein E and the prevalence of dementia and Alzheimer’s disease in the Rotterdam Study”, Lancet 349, 151–154.
   PubMed Web of Science ®Google Scholar
• Hollman, P.C.H., Gaag, M.V.D., Mengelers, M.J.B., Trijp, J.M.P., Vries, J.H.M. and Katan, M.B. (1995 ) “Absorption and disposition kinetics of the dietary antioxidant quercetin in man”, Free Radical Biology and Medicine 21, 703–707.
   Web of Science ®Google Scholar
• Hollman, P.C.H., Vries, J.H.M., Leeuwen, S.D., Mengelers, M.J.B. and Katan, M.B. (1996 ) “Absorption of dietary quercitin glycosides and quercetin in healthy ileostomy volunteers”, American Journal of Clinical Nutrition 62, 1276–1282.
   Web of Science ®Google Scholar
• Horrobin, D.F., Manku, M.S., Morse-Fisher, N., Vaddadi, K.S., Courtney, P., Glen, A.I.M., Glen, E., Spellman, M. and Bates, C. (1989 ) “Essential fatty acids in plasma phospholipids in schizophrenics”, Biological Psychiatry 25, 562–568.
   PubMed Web of Science ®Google Scholar
• Hunter, R., Blackwood, W., Smith, M.C. and Cumings, J.N. (1968 ) “Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication”, Journal of Neurological Science 7, 263–273.
   PubMed Web of Science ®Google Scholar
• Jama, W.J., Launer, L.J., Witteman, J.C.M., den-Breeijn, H., Breteler, M.M.B. and Hofman, A. (1996) “Dietary antioxidants and cognitive function in a population-based sample of older persons: the Rotterdam study”, American Journal of Epidemiology 144, 275–280.
   PubMed Web of Science ®Google Scholar
• Jenner, P. (1994 ) “Oxidative damage in neurodegenerative disease”, Lancet 344, 796–799.
   PubMed Web of Science ®Google Scholar
• Jenner, P. and Olnaw, C.W. (1996 ) “Oxidative stress and the pathogenesis of Parkinson’s disease”, Neurology 47 (Suppl.), S161–S176.
   PubMedGoogle Scholar
• Johnston, J.A., Dalton, M.J., Gurney, M.E. and Kopito, R.R. (2000 ) “Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis”, Proceedings of the National Academy of the Sciences of the USA 7, 12571–12576.
   Google Scholar
• Joseph, J.A. (1992 ) “The putative role of free radicals in the loss of neuronal functioning in senescence”, Integrated Physiology and Behavioral Science 27, 216–217.
   PubMedGoogle Scholar
• Joseph, J.A., Shukitt-Hale, B., Denivosa, N.A., Prior, R.L., Cao, G., Martin, A., Taglialatela, G. and Bickford, P.C. (1998 ) “Long-term dietary strawberry, spinach or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits”, Journal of Neuroscience 18, 8047–8055.
   PubMed Web of Science ®Google Scholar
• Joseph, J.A., Shukitt-Hale, B., Denivosa, N.A., Bielinski, D., Martin, A., McEwen, J.J. and Bickford, P.C. (1999 ) “Reversals of age-related declines in neuronal signal transduction, cognitive and motor behavioral deficits with blueberry, spinach or strawberry dietary supplementation”, Journal of Neuroscience 19, 8114–8121.
   PubMed Web of Science ®Google Scholar
• Joseph, J.A., Denisova, N.A., Bielinski, D., Fisher, D.R. and Shukitt-Hale, B. (2000) “Oxidative stress protection and vulnerablility in aging: putative nutritional implications for intervention”, Mechanism of Aging and Development 116, 141–153.
   PubMed Web of Science ®Google Scholar
• Julien, J.-P., Couillard-Despres, S. and Meier, J. (1999 ) “Transgenic mice in the study of ALS: the role of neurofilaments”, Brain Pathology 8, 759–769.
   Web of Science ®Google Scholar
• Kalaria, R.N. and Ballard, C. (1999 ) “Overlap between pathology of Alzheimer’s disease and vascular dementia”, Alzheimer’s Disease and Associated Disorders 13 (Suppl. 3), S115–S123.
   PubMed Web of Science ®Google Scholar
• Kanowski, S., Herrmann, W.M., Stephan, K., Wierich, W. and Horr, R. (1996 ) “Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia”, Pharmacopsychiatry 29, 47–56.
   PubMed Web of Science ®Google Scholar
• Karas, M., Amir, H., Fishman, D., Danilenko, M., Segal, S., Nachum, A., Koifman, A., Giat, Y., Levy, J. and Sharoni, Y. (2000 ) “Lycopene interferes with cell cycle progression and insulin-like growth factor-I signaling in mammary cancer cells”, Nutrition and Cancer 36, 101–111.
   PubMed Web of Science ®Google Scholar
• Kato, S., Shimoda, M., Watanabe, Y., Nakashima, K., Takahashi, K. and Ohama, E. (1996 ) “Familial amyotrophic sclerosis with a two base pair deletion in superoxide dismutase gene: multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes”, Journal of Neuropathology and Experimental Neurology 55, 1089–1101.
   PubMed Web of Science ®Google Scholar
• Kaul, S. and Krishnakantha, T.P. (1997 ) “Influence of retinal deficiency and curcumin/turmeric feeding on tissue microsomal membrane lipid peroxidation and fatty acids in rats”, Molecular and Cellular Biochemistry 175, 43–48.
   PubMed Web of Science ®Google Scholar
• Kelloff, G.J., Crowell, J.A., Hawk, E.T., Steele, V.E., Lubet, R.A., Boone, C.W., Covey, J.M., Doody, L.A., Omenn, G.S., Greenwald, P., Hong, W.K., Pakinson, D.R., Bagher, D., Baxter, G.T., Blunden, M., Doeltz, M.K., Eisenhauer, K.M., Johnson, K., Knapp, G.G., Longfellow, D.G., Malone, W.F., Nayfield, S.G., Seifried, H.E., Swall, L.M. and Sigman, C.C. (1996 ) “Strategy and planning for chemopreventive drug development:clinical development plan: curcumin”, Journal of Cellular Biochemistry 26, 72–85.
   Google Scholar
• Kennard, M.L., Feldman, H. and Yamada, T. (1996 ) “Serum levels of the iron protein p97 are elevated in Alzheimer’s disease”, Nature Medicine 2, 1230–1235.
   PubMed Web of Science ®Google Scholar
• Kish, S.J., Morito, C. and Hornykiewicz, O. (1985 ) “Glutathione peroxidase activity in Parkinson’s disease”, Neuroscience Letters 58, 343–346.
   PubMed Web of Science ®Google Scholar
• Kleijnen, J. and Knipschild, P. (1992) “Ginkgo biloba for cerebral insufficiency”, British Journal of Clinical Pharmacology 34, 352–358.
   PubMed Web of Science ®Google Scholar
• Kobayashi, M.S., Han, D. and Packer, L. (2000 ) “Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate- induced cytotoxicity”, Free Radical Research 32, 115–124.
   PubMed Web of Science ®Google Scholar
• Koroshetz, W.J., Jenkins, B.G., Rosen, B.R. and Beal, M.F. (1997 ) “Energy metabolism defects in Huntington’s disease and effects of coenzyme Q10”, Annals of Neurology 41, 160–165.
   PubMed Web of Science ®Google Scholar
• Kucuk, O., Sarkar, F.H., Sakr, W., Djuric, Z., Pollak, M.N., Khachik, F. , Li, Y.W., Banerjee, M., Grignon, D., Bertram, J.S., Crissman, J.D., Pontes, E.J. and Wood, Jr., D.P. (2001) “Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy”, Cancer Epidemiology, Biomarkers and Prevention 10, 861–868.
   PubMed Web of Science ®Google Scholar
• Langston, J.W., Ballard, P. and Tetrud, J.W. (1983 ) “Chronic Parkinsonism in humans due to meperidine synthesis”, Science 219, 979–980.
   PubMed Web of Science ®Google Scholar
• Lim, G.P., Chu, T., Yang, F., Beech, W., Frautschy, S.A. and Cole, G. M. (2001 ) “The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse”, Journal of Neuroscience 21, 8370–8377.
   PubMed Web of Science ®Google Scholar
• Lippa, C.F., Smith, T.W., Saunders, A.M., Hulette, C., Pulaski-Salo, D. and Roses, A.D. (1997), Neurology 48, 515–519.
   PubMed Web of Science ®Google Scholar
• Liu, R., Althaus, J.S., Ellerbrock, B.R., Becker, D.A. and Gurney, M.E. (1998 ) “Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis”, Annals of Neurology 44, 763–770.
   PubMed Web of Science ®Google Scholar
• Liu, R., Li, B., Flanagan, S.W., Oberley, L.W., Gozal, D. and Qiu, M. (2002 ) “Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival”, Journal of Neurochemistry 80, 488–500.
   PubMed Web of Science ®Google Scholar
• Llesuy, S., Milei, J., Gonzalez Flecha, B. and Boveris, A. (1994 ) “Myocardial damage induced by doxorubicins: hydroperoxide- initiated chemiluminescence and morphology”, Journal of Free Radical Biology and Medicine 8, 259–264.
   Google Scholar
• Lohr, J.B., Cadet, J.L., Lohr, M.A., Larson, L., Wasli, E., Wade, L., Hylton, R., Vidoni, C., Jeste, D.V. and Wyatt, R.J. (1988 ) “Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms”, Schizophrenia Bulletin 14, 291–296.
   PubMed Web of Science ®Google Scholar
• Lohr, J.B., Kuczenski, R., Bracha, H.S., Moir, M. and Jeste, D.V. (1990 ) “Increased indices of free radical activity in the cerebrospinal fluid of patients with Tardive dyskinesia”, Biological Psychiatry 28, 535–539.
   PubMed Web of Science ®Google Scholar
• Longnecker, M.P., Kamel, F., Umbach, D.M., Munsat, T.L., Shefner, J.M., Lansdell, L.W. and Sandler, D.P. (2000 ) “Dietary intake of calcium, magnesium and antioxidants in relation to risk of amyotrophic lateral sclerosis”, Neuroepidemiology 19, 210–216.
   PubMed Web of Science ®Google Scholar
• Louwerse, E.S., Weverling, G.J., Bossuyt, P.M., Meyjes, F.E. and de Jong, J.M. (1995 ) “Randomizd, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis”, The Archives of Neurology 52, 559–564.
   PubMed Web of Science ®Google Scholar
• Lovell, M.A., Ehmann, W.D., Butler, S.M. and Markesberg, W.R. (1995 ) “Elevated thiobarbituric acid reactive substances and antioxidant enzyme activity in the brain in Alzheimer’s disease”, Neurology 45, 1594–1601.
   PubMed Web of Science ®Google Scholar
• Markesbery, W.R. (1997 ) “Oxidative stress hypothesis in Alzheimer’s disease”, Free Radical Biology and Medicine 23, 134–147.
   PubMed Web of Science ®Google Scholar
• Markesbery, W.R. (1999 ) “The role of oxidative stress in Alzheimer’s disease”, The Archives of Neurology 56, 1449–1452.
   PubMedGoogle Scholar
• Markesbery, W.R. and Carney, J.M. (1999 ) “Oxidative alterations in Alzheimer’s disease”, Brain Pathology 9, 133–146.
   PubMed Web of Science ®Google Scholar
• Markesbury, W. and Ehmonn, A. (1993 ) “Brain trace elements in Alzheimer’s disease”, In: Terry, R., Atzman, R. and Bick, K., eds, Alzheimer’s Disease (Raven Press, New York).
   Google Scholar
• Martins, R.N., Harper, C.G., Stokes, G.B. and Masters, C.L. (1986 ) “Increased cerebral glucose 6-phosphate dehydrogenase activity in Alzheimer’s disease may reflect oxidative stress”, Journal ofNeurochemistry 46, 1042–1045.
   PubMed Web of Science ®Google Scholar
• Masaki, K.H., White, L.R. and Petrovich, H. (1994 ) “The influence of prior and concurrent use of aspirin and vitamins on cognitive function scores in elderly Japanese-American men. Fourth International Conference on Alzheimer’s disease and Related disorders”, Neurobiology of Aging 15, S1, Fourth International Conference on Alzheimer’s disease and Related disorders.
   PubMedGoogle Scholar
• Mayeux, R. and Sano, M. (1999 ) “Treatment of Alzheimer’s disease”, New England Journal of Medicine 341, 1670–1679.
   PubMed Web of Science ®Google Scholar
• Mazur Koleeka, B., Frackowiak, J., Kowal, D., Krzeslowska, J. and Dickson, D. (2002 ) “Oxidative protein damage in cells engaged in beta-amyloidosis is related to apoE genotype”, Neuroreport 13, 465–468.
   PubMed Web of Science ®Google Scholar
• McKenna, D.J., Jones, K. and Hughes, K. (2001 ) “Efficacy, safety and use of Ginkgo biloba in clinical and preclinical applications”, Alternative Therapies in Health and Medicine 7, 70–86.
   PubMed Web of Science ®Google Scholar
• Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T. and Kagawa, Y. (1989 ) “Deficiencies in complex I subunits of the respiratory chain in Parkinson’s disease”, Biochemical Biophysical Research Communications 163, 1450–1455.
   PubMed Web of Science ®Google Scholar
• Moncada, S., Palmer, R.M.J. and Higgs, E.A. (1989 ) “Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of the cell function and communication”, Biochemical Pharmacology 38, 1709–1715.
   PubMed Web of Science ®Google Scholar
• Moosmann, B. and Behl, C. (1999 ) “The antioxidant neuroprotec- tive effects of estrogens and phenolic compounds are independent from their estrogenic properties”, Proceedings of the National Academy of Sciences of the USA 96, 8867–8872.
   PubMed Web of Science ®Google Scholar
• Moosmann, B. and Behl, C. (2000 ) “Cytoprotective antioxidant function of tyrosine and tryptophan residues in transmembrane proteins”, European Journal of Biochemistry 267, 5687–5692.
   PubMedGoogle Scholar
• Moosmann, B. and Behl, C. (2001) “Antioxidants as treatment for neurodegenerative disorders”, Expert Opinion on Investigational Drugs, In press.
   Web of Science ®Google Scholar
• Morgenstern, H. and Glazer, W.M. (1993 ) “Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications”, Archives of General Psychiatry 50, 723–733.
   PubMed Web of Science ®Google Scholar
• Morris, D.L., Kritchevsky, S.B., Davis, C.E. (1994 ) “Serum carotenoids and coronary heart disease: the Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study”, JAMA 272, 1439–1441.
   PubMed Web of Science ®Google Scholar
• Morris, M.C., Bechett, L.A., Scherr, P.A., Herbert, L.E., Bennett, D. A., Field, T.S. and Evans, D.A. (1998 ) “Vitamin E and vitamin C supplement use and risk of incident Alzheimer’s disease”, Alzheimer’s Disease and Associated Disorders 12, 121–126.
   PubMed Web of Science ®Google Scholar
• Mukherjee, S., Reddy, R. and Schnur, D.B. (1991 ) “Diabetes mellitus and tardive dyskinesia”, Biological Psychiatry 1, 624–627.
   Google Scholar
• Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C.L. and Beyreuther, K. (1996 ) “The amyloid precursor protein of Alzheimer’s disease in the reduction of copper(II) to copper(I)”, Science 271, 1406–1409.
   PubMed Web of Science ®Google Scholar
• Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E. and Ikeda, K. (1991 ) “Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease”, Brain Research 541, 163–166.
   PubMed Web of Science ®Google Scholar
• Naoi, M. (1993 ) “N-Methylated tetrahydroisoquinoline as dopaminergic neurotoxins”, Advances in Neurology 60, 212–217.
   PubMedGoogle Scholar
• Nguyen, M.L. and Schwartz, S.J. (1989 ) “Lycopene: chemical and biological properties”, Food Technology 53, 38–45.
   Google Scholar
• Oken, B.S., Storzbach, D.M. and Kaye, J.A. (1998 ) “The efficacy of Ginkgo biloba on cognitive function in Alzheimer’s disease”, The Archives of Neurology 55, 1409–1415.
   PubMed Web of Science ®Google Scholar
• Olney, J.W. (1989 ) “Excitatory amino acids and neuropsychiatric disorders”, Biological Psychiatry 26, 505–525.
   PubMed Web of Science ®Google Scholar
• Olsen, M.K., Roberds, S.L., Ellerbrock, B.R., Fleck, T.J., Mckinley, D. K. and Gurney, M.E. (2001 ) “Disease mechanisms revealed by transcription profiling in SOD1–G93A transgenic mouse spinal cord”, Annals of Neurology 50, 730–740.
   PubMed Web of Science ®Google Scholar
• Orgogozo, J.M., Dartigues, J.F., La font, S., Letenneur, L., Commenges, D., Salomon, R., Renaud, S. and Breteler, M.B. (1997) “Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area”, Revue Neurologique 153, 185–192.
   PubMed Web of Science ®Google Scholar
• Orrell, R.W. (2000 ) “Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD1) gene mutation”, Neuromuscular Disorders 10, 63–68.
   PubMed Web of Science ®Google Scholar
• Oyama, Y.A., Hayashi, H. and Ueha, T. (1993 ) “Ca2+-induced increase in oxidative metabolism of dissociated mammalian brain neurons: effect of extract of Ginkgo biloba leaves”, Japanese Journal of Phamacology 61, 367–370.
   PubMed Web of Science ®Google Scholar
• Oyama, Y., Fuchs, P.A., Katayama, N. and Noda, K. (1994 ) “Myricetin and quercitin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca + loaded brain neurons”, Brain Research 635, 125–129.
   PubMed Web of Science ®Google Scholar
• Packer, J.E., Mahood, J.S., Mora-Arellano, V.O., Slater, T.F., Wilson, R.L. and Wolfenden, B.S. (1981 ) “Free radicals and singlet oxygen scavangers: Reaction of a peroxy-radical with ß-carotene, Diphenyl Furan and 1,4-diazobicyclo (2,2,2)- octane”, Biochemical Biophysical Research Communication 98, 901–906.
   PubMed Web of Science ®Google Scholar
• Packer, L. (1995) “Oxidative stress, antioxidants, aging and disease”, In: Cutler, R.G., Packer, L. and Mori, L., eds, Oxidative Stress and Aging (Birkauser Verlag Basel, Switzerland ), pp. 1–14.
   Google Scholar
• Papolla, M., Omar, R., Kim, K. and Robakis, N. (1994 ) “Immunohistochemical evidence of antioxidant stress in Alzheimer’s disease”, American Journal of Pathology 140, 621–628.
   Web of Science ®Google Scholar
• Perrin, R., Briancon, S., Jeandel, C., Artur, Y., Minn, A., Penin, F. and Siest, G. (1990 ) “Blood activity of Cu-Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer’s disease: a case-control study”, Gerontology 36, 306–313.
   PubMed Web of Science ®Google Scholar
• Perry, T.L. and Hansen, S. (1990 ) “What excitotoxin kills striatal neurons in Huntingtons disease? Clues from neurochemical studies”, Neurology 40, 20–24.
   PubMed Web of Science ®Google Scholar
• Perry, W.J., Perry, P. and Stahelin, H.B. (1997 ) “The relation between antioxidants and memory performance in the old and very old”, Journal of the American Geriatric Society 45, 718–724.
   PubMed Web of Science ®Google Scholar
• Pfianz, S., Besson, J.A., Ebmeier, K.P. and Simpson, S. (1991 ) “The clinical manifestation of mental disorder in Huntington’s disease: a respective case record in study of disease progression”, Acta Psychiatrica Scandinavica 83, 53–60.
   PubMed Web of Science ®Google Scholar
• Plaitakis, A., Constantakakis, E. and Smith, J. (1988 ) “The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis”, Annals of Neurology 24, 446–449.
   PubMed Web of Science ®Google Scholar
• Pryor, W. and Godber, S.S. (1991 ) “Noninvasive measures of oxidative stress status in humans”, Free Radical Biology and Medicine 10, 177–184.
   PubMed Web of Science ®Google Scholar
• Quinlan, G.J., Halliwell, B. and Moorhouse, C.P. (1988 ) “Action of lead(II) and aluminium(III) ions on iron-stimulated lipid peroxides on liposomes, erythrocytes and rat liver microsomal fractions”, Biochimica et Biophysica Acta 96, 196–200.
   Google Scholar
• Rafalowska, U., Liu, G.-J. and Floyd, R.A. (1989 ) “Peroxidation of induced changes in synaptosomal transport of dopamine and gamma-aminobutyric acid”, Free Radical Biology Medicine 6, 485–492.
   PubMed Web of Science ®Google Scholar
• Rai, G.S., Shovlin, C. and Wesnes, K.A. (1991 ) “A double blind, placebo controlled study of Ginkgo biloba extract (Tanaken) in elderly patients with mild to moderate memory impairment”, Current Medical Research Opinion 12, 350–355.
   PubMed Web of Science ®Google Scholar
• Rajakrishnan, V., Viswanathan, P., Rajasekharan, K.N. and Menon, V.P. (1999 ) “Neuroprotective role of curcumin from curcuma longa on ethanol-induced brain damage”, Phytotherapy Research 13, 571–574.
   PubMed Web of Science ®Google Scholar
• Ramassamy, C., Averill, D., Beffert, U., Bastianetto, S., Theroux, L., Lussiercacan, S., Cohn, J.S., Christen, Y., Davignon, J., Quirion, R. and Poirier, J. (1999 ) “Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer’s disease is related to the apolipoprotein E genotype”, Free Radical Biology and Medicine 27, 544–553.
   PubMed Web of Science ®Google Scholar
• Rao, A.V. and Agarwal, S. (1998 ) “Effect of diet and smoking on serum lycopene and lipid peroxidation”, Nutrition Research 18, 713–721.
   Web of Science ®Google Scholar
• Repetto, M.G., Reides, C.G., Evelson, P., Kohan, S., de Lustig, E.S. and Llesuy, S.F. (1999 ) “Peripheral markers of oxidative stress in probable Alzheimer patients”, European Journal of Clinical Investigation 29, 643–649.
   PubMed Web of Science ®Google Scholar
• Riemenschneider, M., Schmolke, M., Lautenschlager, N., Vanderstichele, H., Vanmechelen, E., Guder, W.G. and Kurz, A. (2002 ) “Association of CSF apolipoprotein E, Abeta42 and cognition in Alzheimer’s disease”, Neurobiology of Aging 23, 205–211.
   PubMed Web of Science ®Google Scholar
• Rimm, E.B., Stampfer, M.J., Ascherio, A., Giovannuci, E., Colditz, G. A. and Willett, W.C. (1993 ) “Vitamin E consumption and the risk of coronary heart disease”, New England Journal of Medicine 328, 1450–1456.
   PubMed Web of Science ®Google Scholar
• Rijke, Y.B., Demacker, P.N.M., Assen, N.A., Sloots, L.M., Katan, M.B. and Stalenhoef, A.F.H. (1996 ) “Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers”, American Journal Clinical Nutrition 63, 329–334.
   PubMed Web of Science ®Google Scholar
• Robak, J. and Gryglewski, R.J. (1988 ) “Flavanoids are scavengers of superoxide anions”, Biochemical Pharmacology 37, 837–841.
   PubMed Web of Science ®Google Scholar
• Robberecht, W., Sapp, P., Viaene, M.U., Rosen, D., McLenna, Y.D., Hames, J., Horovitz, R., Theys, P. and Brown, R. (1994 ) “Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis”, Journal of Neurochemistry 62, 1384–1387.
   Google Scholar
• Rockwood, K., Kirkland, S., Hogan, D.B., MacKnight, C., Merry, H. , Verreault, R., Wolfson, C. and McDowell, I. (2002) “Use of lipid-lowering agents, indication bias, and the risk of dementia in immunity-dwelling elderly people”, Archives of Neurology 59, 223–237.
   PubMed Web of Science ®Google Scholar
• Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O’Regan, J.P., Deng, H.-X., Rahman, Z., Krizus, A., McKenna-Yasek, D., Gayabyab, A., Gaston, S.M., Berger, R., Tanzi, R.E., Halperin, J.J., Hertzfeld, B., Van der Bergh, R., Hung, W.-Y., Bird, T., Deng, G., Mulder, D.W., Smyth, C., Laing, N.G., Soriano, E., Pericak-Vance, M.A., Haines, J., Rouleau, G.A., Gusella, J.S., Horvitz, H.R. and Brown, Jr., R.H. (1993 ) “Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis”, Nature 362, 59–62.
   PubMed Web of Science ®Google Scholar
• Roses, A.D. (1997 ) “A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer’s disease”, Neurogenetics 1, 3–11.
   PubMed Web of Science ®Google Scholar
• Rossetti, A.L., Sotgiu, A., Sharp, D.E., Hadjiconstantinou, M. and Neff, N.H. (1988 ) “1-Methyl-4-phenyl-1,2,3,6-tetrahydropyri- dine (MPTP) and free radicals in vitro”, Biochemical Pharmacology 37, 4573–4574.
   PubMed Web of Science ®Google Scholar
• Rossjohn, J., Cappai, R., Feil, S.C., Henry, A., McKinstry, W.J., Galatis, D., Hesse, L., Multhaup, G., Beyreuther, K., Masters, C.L. and Parker, M.W. (1999 ) “Crystal structure of the N-terminal growth factor-like domain of Alzheimer amyloid precursor protein”, Nature Structural Biology 6, 327–331.
   PubMedGoogle Scholar
• Rothstein, J.D., Bristol, L.A., Hosler, B., Brown, Jr., R.H. and Kuncl, R.W. (1994 ) “Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons”, Proceedings of the National Academy of Sciences of the USA 91, 4155–4159.
   PubMed Web of Science ®Google Scholar
• Ruiz, F.H., Gonzalez, M., Bodini, M., Opazo, C. and Inestrosa, N.C. (1999 ) “Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein”, Journal of Neurochemistry 73, 1288–1292.
   PubMed Web of Science ®Google Scholar
• Sanchez-Ramos, J.R., Overik, E. and Ames, B.N. (1994 ) “A marker of oxyradical-mediated DNA damage (8-hydroxy-2deoxygua- nosine) is increased in nigro striatum of Parkinson’s disease brain”, Neurodegeneration 3, 197–204.
   Google Scholar
• Sano, M., Ernesto, M.S., Thomas, R.G., Klauber, M.R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C.W., Pfeiffer, E., Schneider, L.S. and Thal, L.J. (1997 ) “A controlled trial of selegiline, alpha tocopherol or both as treatment for Alzheimer’s disease”, New England Journal of Medicine 336, 1216–1222.
   PubMed Web of Science ®Google Scholar
• Sayre, L.M., Perry, G., Harris, P.L.R., Liu, Y.H., Schubert, K.A. and Smith, M.A. (2000 ) “In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer’s disease: a central role for bound transition metals”, Journal of Neurochemistry 74, 270–279.
   PubMed Web of Science ®Google Scholar
• Schmidt, R., Fazekas, F., Hayn, M., Schmidt, H., Kapeller, P., Roob, G., Offenbacher, H., Schumacher, M., Eber, B., Weinrauch, V., Kostner, G.M. and Esterbauer, H. (1997 ) “Risk factors for microangiopathy-related cerebral damage in Austrian stroke prevention study”, Journal ofNeurological Science 152, 15–21.
   PubMed Web of Science ®Google Scholar
• Schmidt, R., Hayn, M., Reihart, B., Roob, G., Schmidt, H., Schumbacher, M., Watzinger, N. and Launer, L.J. (1998 ) “Plasma antioxidants and cognitive performance in middle aged and older adults: results of the Austrian stroke prevention study”, Journal of the American Geriatric Society 46, 1407–1410.
   PubMed Web of Science ®Google Scholar
• Schulz, J.B., Henshaw, D.R., Siwek, D., Jenkins, B.G., Ferrante, R.J., Cipolloni, P.B., Kowall, N.W., Rosen, B.R. and Beal, M.F. (1995 ) “Involvement of free radicals in excitotoxicity in vivo”, Journal of Neurochemistry 64, 2239–2247.
   PubMed Web of Science ®Google Scholar
• Schwarcz, R., Ocuno, E., White, R.J., Bird, E.D. and Whetsell, Jr., W.O. (1988 ) “3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims”, Proceedings of National Academy of Sciences of the USA 85, 4079–4081.
   PubMed Web of Science ®Google Scholar
• Selkoe, D.J. (1997 ) “Alzheimer’s disease: genotype, phenotype and treatments”, Science 275, 630–631.
   PubMed Web of Science ®Google Scholar
• Shamir, E., Barak, Y., Shalman, I., Laudon, M., Zisapel, N., Tarrasch, R., Elizur, A. and Weizman, R. (2001 ) “Melatonin treatment for tardive dyskinesia: a double-blind, placebocontrolled, crossover study”, Archives of General Psychiatry 58, 1049–1052.
   PubMed Web of Science ®Google Scholar
• Sharoni, Y., Danilenko, M. and Levy, J. (2000 ) “Molecular mechanisms for the anticancer activity of the carotenoid lycopene”, Drug Development Research 50, 448–456.
   Web of Science ®Google Scholar
• Shaw, PJ. and Eggett, C.J. (2000 ) “Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis”, Journal of Neurology 247 (Suppl. 1), 117–127.
   PubMedGoogle Scholar
• Shaw, P.J., Ince, P.G., Falkous, G. and Mantle, D. (1995 ) “Oxidative damage to protein in sporadicmotor neuron disease spinal cord”, Annals of Neurology 38, 691–695.
   PubMed Web of Science ®Google Scholar
• Shibata, N., Hirano, A., Kobayashi, M., Dalcanto, M.C., Gurney, M.E., Komori, T., Umahara, T. and Asayama, K. (1998 ) “Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD”, Acta Neuropathologica (Berl) 95, 136–142.
   PubMed Web of Science ®Google Scholar
• Sian, J., Dexter, D.T. and Less, A.J. (1994 ) “Alteration in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affective basal ganglia”, Annals of Neurology 36, 348–355.
   PubMed Web of Science ®Google Scholar
• Sinclair, A.J., Bayer, A.J., Johnston, J., Warner, C. and Mawxell, S.R. (1998 ) “Altered plasma antioxidant status in subjects with Alzheimer’s disease and vascular dementia”, International Journal of Geriatric Psychiatry 13, 840–845.
   PubMed Web of Science ®Google Scholar
• Sinha, B.K., Singh, Y. and Krishna, G. (1986 ) “Formation of superoxide and hydroxyl radicals from 1-methyl-4 phenylpyr- idinium ion (MPP + ): reductive activation by NAdPH cytochrome P450 reductase”, Biochemical Biophysical Research Communications 135, 83–88.
   Web of Science ®Google Scholar
• Slooter, A.J.C., Cruts, M., Ott, A., Bots, M.L., Witteman, J.C.M., Hofman, A., van Broeckhoven, C., Breteler, M.M.B. and van Duijn, C.M. (1999 ) “The effect of apoE on dementia is not through atherosclerosis: the Rotterdam Study”, Neurology 53, 1593–1595.
   PubMed Web of Science ®Google Scholar
• Smith, M.A., Harris, P.L.R., Sayre, L.M. and Perry, G. (1997 ) “Iron accumulation in Alzheimer’s disease is a source of redoxgenerated free radicals”, Proceedings of the National Academy Sciences of the USA 94, 9866–9868.
   PubMed Web of Science ®Google Scholar
• Smith, M.A., Hirai, K., Hsiao, K., Pappolla, M.A., Harris, P.L.R., Siedlak, S.L., Tabaton, M. and Perry, G. (1998 ) “Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress”, Journal of Neurochemistry 70, 2212–2215.
   PubMed Web of Science ®Google Scholar
• Smith, R.G., Henry, Y.K., Mattson, M.P. and Appel, S.H. (1998 ) “Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis”, Annals of Neurology 44, 696–699.
   PubMed Web of Science ®Google Scholar
• Snowdon, D.A., Gross, M.D. and Butler, S.M. (1996) “Antioxidants and reduced functional capacity in the elderly: finding from the Nun Study”, Journal of Gerontology Series A—Biological Sciences and Medical Sciences 51, M10 -M16.
   PubMed Web of Science ®Google Scholar
• Sreejayan, N. and Rao, M.N.A. (1997 ) “Nitric oxide scavenging by curcuminoids”, Journal of Pharmacy and Pharmacology 49, 105–107.
   PubMed Web of Science ®Google Scholar
• Stahl, W. and Sies, H. (1996 ) “Lycopene: a biologically important carotenoid for humans?”, Archives of Biochemistry and Biophysics 336, 1–9.
   PubMed Web of Science ®Google Scholar
• Stewart, R., Prince, M. and Mann, A. (1999 ) “Vascular risk factors and Alzheimer’s disease”, Australian and New Zealand Journal of Psychiatry 33, 809–813.
   PubMed Web of Science ®Google Scholar
• Subbarao, K.V., Richardson, J.S. and Ang, L.C. (1990 ) “Autopsy samples of Alzheimer’s cortex show increased peroxidation in vitro”, Journal of Neurochemistry 55, 342–345.
   PubMed Web of Science ®Google Scholar
• Subirade, I., Fernandez, I., Fernandez, Y., Periquet, A. and Mitjavila, S. (1995 ) “Catechin protection of 3T3 Swiss fibroblasts in culture under oxidative stress”, Biology and Trace Element Research 47, 313–319.
   PubMed Web of Science ®Google Scholar
• Swartz, H.M., Sarna, T. and Zecca, L. (1992 ) “Modulation by neuromelanin of the availability and reactivity of metal ions”, Annals of Neurology 32, S69–S75.
   PubMed Web of Science ®Google Scholar
• Takahashi, T., Yagishita, S., Amano, N., Yamaoka, K. and Kamei, T. (1997 ) “Amyotrophic lateral sclerosis with numerous axonal spheroids in the corticospinal tract and massive degeneration of the cortex”, Acta Neuropathologica 94, 294–299.
   PubMed Web of Science ®Google Scholar
• Tellez-Nagel, I., Johnson, A.B. and Terry, R.D. (1973 ) “Ultra- strucutural and histochemical study of cerebral biopsies in Huntington’s chorea ”, In: Barbeau, A., Chase, T.N. and Paulson, G. W., eds, Advances in Neurology (Raven Press, New York, NY ), pp. 387–398.
   Google Scholar
• The Huntington ’s Disease Collaborative Research Group(1993 ) “A novel gene containing a trinucleotide repeat that is expended and unstable on Huntington’s disease chromosomes”, Cell 72, 971–983.
   Google Scholar
• Thienhaus, O.J., Cliffe, C., Zemlan, F.P. and Bosman, H.B. (1986 ) “Superoxide dismutase, chromosome 21, and Alzheimer’s disease”, Biological Psychiatry 21, 1101–1109.
   PubMedGoogle Scholar
• Tohgi, H., Abe, T. and Nakanishi, M. (1994 ) “Concentrations of a-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanga type and Alzheimer’s type dementia”, Neuroscience Letters 174,73–76.
   PubMed Web of Science ®Google Scholar
• Tomiyama, T., Corder, E.H. and Mori, H. (1999 ) “Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late- onset Alzheimer’s disease”, Cellular and Molecular Life Sciences 56, 268–279.
   PubMed Web of Science ®Google Scholar
• Troy, C.M. and Shelanski, M.L. (1994 ) “Down-regulation of copper/zinc superoxide dismautase causes apoptotic death in PC12 neuronal cells”, Proceedings of the National Academy Sciences of the USA 91, 6384–6387.
   PubMed Web of Science ®Google Scholar
• Van Rensburg, S.J., Carstens, M.E. and Potocnik, F.C. (1995 ) “Transferrin C2 and Alzheimer’s disease: another piece of the puzzle found”, Medical Hypotheses 44, 268–272.
   PubMed Web of Science ®Google Scholar
• Vatassery, G.T., Fahn, S. and Kuskowski, M.A. (1998 ) “a-Tocopherol in CSF of subjects taking high-dose vitamin E in the Data top study. Parkinson Study Group”, Neurology 50, 1900–1902.
   PubMed Web of Science ®Google Scholar
• Velier, J., Kim, M., Schwarz, C., Kim, T.M., Sapp, E., Chase, K., Aronin, N. and Difiglia, M. (1998 ) “Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways”, Experimental Neurology 152, 34–40.
   PubMed Web of Science ®Google Scholar
• Vinken, P.J. and Bruyn, G.W. (1977) Handbook of Clinical Neurology (North Holland Publishing, New York, NY).
   Google Scholar
• Volicer, L. and Crino, P.B. (1990 ) “Involvement of free radicals in dementia of the Alzheimer’s type: a hypothesis”, Neurobiology of Aging 11, 567–571.
   PubMed Web of Science ®Google Scholar
• Vyth, A., Timmer, J.G., Bossuyt, P.M., Louwerse, E.S. and de Jong, J.M. (1996 ) “Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants”, Journal of Neurological Science 139 (Suppl.), 99–103.
   PubMed Web of Science ®Google Scholar
• Weiner, M.F., Sohal, R.J., Balin, A.S., Whitee, III, C.L. and Allen, R.G. (1988 ) “Antioxidant enzymes in Alzheimer’s disease”, Abstracts of the First International Conference on Alzheimer’s Disease and Associated Disorders Vol. 2, p. 290.
   Google Scholar
• White, A.R., Multhaup, G., Galatis, D., Mckinstry, W.J., Parker, M.W., Pipkorn, R., Beyreuther, K., Masters, C.L. and Cappai, R. (2002 ) “Contrasting, species-dependent modulation of coppermediated neurotoxicity by the Alzheimer’s disease amyloid precursor protein”, Journal of Neuroscience 22, 365–376.
   PubMed Web of Science ®Google Scholar
• Wiedau-Pazos, M., Goto, J.J., Rabizadeh, S., Gralla, E.B., Roe, J.A., Lee, M., Valentine, J.S. and Bredesan, D.E. (1996 ) “Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis”, Science 271, 515–518.
   PubMed Web of Science ®Google Scholar
• Williams, D.B. and Windebank, A.J. (1991 ) “Motor neurons diseases (amyotrophic lateral sclerosis)”, Mayo Clinic Proceedings 66, 54–82.
   PubMed Web of Science ®Google Scholar
• Woerner, M.G., Saltz, B.Z., Kane, J.M., Lieberman, J.A. and Alvir, J.M.J. (1993 ) “Diabetes and development of tardive dyskinesia”, American Journal of Psychiatry 150, 966–968.
   PubMed Web of Science ®Google Scholar
• Woodall, A.A., Britton, G. and Jackson, M.J. (1997) “Carotenoids and protection of phospholipids in solution or in liposomes against oxidation by peroxy radicals: relationship between carotenoid structure and protective ability”, Biochimica et Biophysica Acta 1336, 575–586.
   PubMed Web of Science ®Google Scholar
• Xu, X., Wang, H.J., Murphy, P.A., Cook, L. and Hendrich, S. (1994 ) “Daidzein is a more bioavailable soymilk isoflavone than is genistine in adult women”, Journal of Nutrition 124, 825–832.
   PubMed Web of Science ®Google Scholar
• Yim, M.B., Kang, J.H., Yim, H.S., Kwak, H.S., Chock, P.B. and Stadtman, E.R. (1996 ) “A gain-of-function of an amyotrophic lateral sclerosis associated Cu, Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide”, Proceedings of the National Academy of Sciences of the USA 93, 5709–5714.
   PubMed Web of Science ®Google Scholar
• Yoitaka, A., Hyttori, N., Uchida, K., Tanaka, N., Stadtman, E.R. and Mizuno, Y. (1996 ) “Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson’s disease”, Proceedings of the National Academy of Sciences of the USA 93, 2696–2701.
   PubMed Web of Science ®Google Scholar
• Youdim, A., Joseph, K. and James, A. (2001 ) “A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects”, Free Radical Biology and Medicine 30, 583–594.
   PubMed Web of Science ®Google Scholar
• Young, A.B., Penney, J.B., Starosta-rubinstein, S., Markel, D.S., Berent, S., Giordani, B., Ehrenkaufer, R., Jewett, D. and Hichwa, R. (1986 ) “PET scan investigations of Huntington’s disease: cerebral metabolic correlates of neurological features and functional decline”, Annals ofNeurology 20, 296–303.
   PubMed Web of Science ®Google Scholar
• Zemlan, F.P., Theinhaus, O.J. and Bosmann, H.B. (1989 ) “Superoxide dismutase activity in Alzheimer’s disease: possible mechanism for paired helical filament formation”, Brain Research 476, 160–162.
   PubMed Web of Science ®Google Scholar
• Zhao, B.L., Li, X.J., He, R.G., Cheng, S.J. and Xin, W.J. (1989 ) “Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals”, Cell Biophysics 14, 175–185.
   PubMedGoogle Scholar